While LMTK2-dependent regulation of BIM was more evident in non-cancer cell lines, other members of the BCL2 family, such as BCL2 and BCL-xL, were regulated by LMTK2 mainly in fully transformed cancer cells. The gene discussed is BCL2L1; the disease is cancer.